Table 4 Comparison of clinical factors between SKP2 Low and SKP2 High groups.

From: The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2

 

SKP2 Low

SKP2 High

P

 

Age (y)

64.23 ± 5.47

66.57 ± 5.33

0.0998

 

cT stage (n)

  

0.0277

*

 1

25

16

  

 2

2

8

  

 3

2

5

  

GS (n)

  

0.0138

*

 6

13

6

  

 7

14

13

  

 8

1

6

  

 9

2

5

  

TST (ng/dL)

5.38 ± 1.87

4.51 ± 1.74

0.0984

 

PSA (ng/mL)

8.68 ± 4.78

12.06 ± 7.70

0.0458

*

PSAD

0.30 ± 0.19

0.43 ± 0.29

0.0360

*

  1. Data are expressed as means ± standard deviation unless otherwise indicated. cT stage = clinical tumour stage, GS = Gleason score, TST = testosterone, PSA = prostate-specific antigen, PSAD = PSA density.
  2. *Statistical significance (p < 0.05).
Back to article page